Physician profile
Glen Gejerman
NPI 1972565182
$180,283.23
in general payments reported to CMS, 2019-2025
12 companies · $37K in 2025
The $37K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,481 · 2020: $4,275 · 2021: $8,749 · 2022: $18K · 2023: $69K · 2024: $38K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $81K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $62K · Food and Beverage: $761 · Travel and Lodging: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $81,225.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $61,600.00 |
| Food and Beverage | $760.84 |
| Travel and Lodging | $165.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $68,352.65 | 2024-2025 | Barrigel |
| Palette Life Sciences, INC. | $64,117.00 | 2022-2023 | |
| Boston Scientific Corporation | $23,804.47 | 2020-2025 | Spaceoar System |
| Novartis Pharmaceuticals Corporation | $13,194.69 | 2023-2025 | Pluvicto |
| Bayer Healthcare Pharmaceuticals INC. | $10,484.54 | 2019-2021 | |
| Teleflex Incorporated | $118.55 | 2023 | Urolift |
| Janssen Biotech, INC. | $63.86 | 2019-2022 | |
| Elekta, INC. | $47.88 | 2022 | |
| Varian Medical Systems, INC. | $29.92 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $29.58 | 2024 | Tagrisso |
| Blue Earth Diagnostics | $29.04 | 2024 | |
| Myriad Genetic Laboratories, INC. | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glen Gejerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.